Abstract:The mechanistic target of rapamycin complex 1 (mTORC1) that regulates cellular gene and protein programming through its downstream signaling components the S6‐kinase and the ribosomal S6 protein serves as an intracellular energy sensor. Emerging evidence points to mTORC1 signaling as an important regulator of cardiovascular function with implications in hypertension. In this study, we tested the hypothesis that endothelial mTORC1 signaling is critically involved in the regulation of vascular endothelial function and that dysregulation of this pathway contributes to endothelial dysfunction. To test this, we generated mice bearing endothelial‐specific mTORC1 disruption by deleting the gene that encodes Raptor, an essential subunit of the complex. For this, we crossed tamoxifen‐inducible endothelial‐specific Cre mice (TekCreERT2) with mice harboring floxed alleles of the Raptor gene. Upon tamoxifen treatment, TekCreERT2/RaptorF/F mice exhibited ~60% reduction in total Raptor expression in endothelial cells (1.0±0.1 vs 0.4±0.1 AU; p<0.05) with no change in Raptor expression in smooth muscle cells (0.8±0.1 vs 1.0±0.1 AU). Tamoxifen treated TekCreERT2/RaptorF/F mice displayed reduced acetylcholine‐mediated endothelial (Max relax: 61±7 vs 34±11%; p<0.05) but not SNP‐induced smooth muscle vasorelaxation responses (Max relax: 84±2 vs 82±3%) in the aorta compared to tamoxifen‐treated wildtype littermates. To demonstrate the importance of mTORC1 signaling in this reduced acetylcholine‐mediated endothelial response in the aorta, we infected TekCreERT2/RaptorF/F aortic rings with an adenoviral S6‐kinase constitutively active construct (Ad‐S6KCA; 24hrs) to restore mTORC1 signaling. Infection with Ad‐S6KCA improved acetylcholine‐mediated endothelial vasorelaxation responses approaching wildtype control levels (Max relax: 54±6 vs 31±10%; p<0.05). We next assessed the effect of heterozygous deletion of endothelial Raptor in mice (TekCreERT2/RaptorF/+). Aortic rings from TekCreERT2/RaptorF/+ displayed intact acetylcholine‐induced vasorelaxation responses compared to tamoxifen‐treated wildtype controls (Max relax: 50±3 vs 49±8%). We next challenged aortic rings from tamoxifen treated TekCreERT2/RaptorF/+ mice with angiotensin II (100nM; 24hrs) to induce endothelial dysfunction. Angiotensin II incubation reduced acetylcholine‐mediated vasorelaxation responses of aortic rings from wildtype mice compared to vehicle (PBS) (Max relax: 57±4 vs 3±8%; p<0.05). Interestingly, aortic rings of TekCreERT2/RaptorF/+ mice treated with tamoxifen were partially protected from the endothelial dysfunction evoked by angiotensin II (Max relax: 3±8 vs 36±9%; p<0.05) indicating that mTORC1 signaling is critical for the vascular effects of angiotensin II. Our data indicate that endothelial mTORC1 signaling is required for the regulation of endothelial function and highlight the need for coordinated balance of mTORC1 signaling for endothelial homeostasis. We speculate that the endothelial mTORC1 signaling pathway may represent a novel target for cardiovascular risks associated with endothelial dysfunction such as hypertension.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Phosphorylation of GATA-6 is Required for Vascular Smooth Muscle Cell Differentiation after Mtorc1 Inhibition.

Methyltransferase Like 3-Mediated N6-methylatidin Methylation Inhibits Vascular Smooth Muscle Cells Phenotype Switching Via Promoting Phosphatidylinositol 3-Kinase Mrna Decay.

Cell-Specific Effects of GATA (GATA Zinc Finger Transcription Factor Family)-6 in Vascular Smooth Muscle and Endothelial Cells on Vascular Injury Neointimal Formation

The mammalian target of rapamycin signalling pathway is involved in osteoblastic differentiation of vascular smooth muscle cells.

Gax Regulates Human Vascular Smooth Muscle Cell Phenotypic Modulation and Vascular Remodeling

Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.

The downstream network of STAT6 in promoting vascular smooth muscle cell phenotypic switch and neointimal formation

Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in the Regulation of S6 Kinase 1 (S6K1) Phosphorylation

Inhibition of Mtor Attenuates Store-Operated Ca2+ Entry in Cells from Endarterectomized Tissues of Patients with Chronic Thromboembolic Pulmonary Hypertension

Mtorc1 (mechanistic Target of Rapamycin Complex 1) Signaling in Endothelial and Smooth Muscle Cells is Required for Vascular Function.

The role of Akt/mTOR signal in TGF-[β-induced arterial endothelial-mesenchymal transition

Mtor REGULATES THE PROLIFERATION AND DIFFERENTIATION OF TENDON STEM CELLS: AN IN VITRO STUDY

Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension.

MTORC1 AND MTORC2 PLAY DIFFERENT ROLES IN THE FUNCTIONAL SURVIVAL OF TRANSPLANTED ADIPOSE-DERIVED STROMAL CELLS IN HINDLIMB ISCHAEMIA MICE VIA REGULATING INFLAMMATION IN VIVO

Mammalian Target of Rapamycin as the Therapeutic Target of Vascular Proliferative Diseases: Past, Present, and Future

Endothelial Mtorc1 Signaling is Required for Vascular Endothelial Function

Abstract 067: Endothelial Mtorc1 Signaling Regulates Vascular Function and Mediates Angiotensin II Actions

FP310MICRORNA493 TARGETS STMN1 AND PROMOTES HYPOXIA INDUCED EPITHELIAL CELL CYCLE ARREST IN G2/MAND RENAL FIBROSIS

The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair

mTOR Signal Transduction Passageway and Myocardial Fibrosis

PI3Kγ is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Modulation and Transplant Arteriosclerosis